Lupkynis® (voclosporin) Granted Marketing Authorization in the European Union for Lupus Nephritis
September 21, 2022
Lupkynis® (voclosporin) was just granted marketing authorization in the European Union as a new treatment for adults...
News
CAR T Cell Therapy Induces Lupus Remission in Small Study
September 21, 2022
Results of a small study published in the prestigious journal Nature Medicine, suggest that a type of immune...
NY Jets Kickoff Luncheon Raises Funds for LRA and Honors Kenneth Farber
September 7, 2022
The New York Jets 2022 football season kicked off last week with a spectacular luncheon that raised...
NIH Awards $500,000 to Advance to Advance Diversity in Lupus Trials
August 31, 2022
We are excited to share good news – our Lupus Clinical Investigators Network, LuCIN, managed by LRA’s...
LRA Earns High Recommendations from Five Groups Evaluating U.S. Charities
September 1, 2022
September 5 is designated by the United Nations as the International Day of Charity – created to...
Long-time Supporter LADA Donates $150,000 to LRA-Funded Research
August 29, 2022
Big thanks go to the Lupus and Allied Diseases Association, Inc. (LADA) for their donation of $150,000...
Lupus Research Alliance Awards $9 Million to Develop Lupus Treatment Breakthroughs
NEW YORK, NY – August 24, 2022 – The Lupus Research Alliance (LRA) today announced its Global Team Science...
New England Journal of Medicine Publishes Positive Data of Litifilimab in Cutaneous Lupus Erythematosus
August, 2022
We are pleased to share positive results from the two-part Phase 2 LILAC study published in the New England...
Lupus Research Alliance designa a Albert Roy como presidente y director ejecutivo
NUEVA YORK, NY. 10 de agosto de 2022. Lupus Research Alliance (LRA) se complace en anunciar el nombramiento de...
Lupus Research Alliance Appoints Albert Roy as President and Chief Executive Officer
NEW YORK, NY. August 10, 2022 – The Lupus Research Alliance (LRA) is pleased to announce the appointment of...
Researchers Discover How Gut Bacteria Can Trigger Autoimmunity
August 4, 2022
Immunologists have found that a certain gut bacteria escapes from the intestines to trigger inflammation that can...
LRA Congratulates GSK on FDA Approval of Benlysta® (belimumab) for Children with Lupus Nephritis
NEW YORK, NY. July 27, 2022. The Lupus Research Alliance (LRA) is pleased to share that the U.S. Food...